The independent source for health policy research, polling, and news.
1,241-1,260 of 3,363 results
The House Republicans’ bill to repeal Obamacare would change how the federal government allocates matching funds to state Medicaid programs — and could cost some states billions of dollars a year in federal aid.
Among the institutions that stand to lose most are those in California, especially the University of California and Stanford University.
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
Barton County, Mo., is Trump country. And this rural area has big problems when it comes to health care. One farmer says he has a lot to lose under the Republican replacement plan.
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
A state with integrated systems for end-of-life care offers better treatment for the seriously ill, according to a new study.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
Blue Shield of California is hoping to steer consumers to "preferred" pharmacies where drugs are cheaper and copays lower.
Two Democratic congressmen met with President Trump to seek his support for a bill to expand the government’s ability to negotiate drug prices, but it’s not clear it would have much impact or will gain support.
Amid an uproar over high drug prices, three GOP senators are asking the Government Accountability Office to investigate whether the Orphan Drug Act is being abused.
Rand Corp. finds that telehealth encourages patients to seek care for minor illnesses they wouldn’t bother to make an office visit for, raising overall health costs.
Researchers believe Californians, many of whom lost health coverage, delayed doctor visits that could have led to earlier detection. Now, with people seeking medical care under the Affordable Care Act, some experts expect to see an increase in late-stage cancers.
After intense negotiations among party factions, Republican leaders unveil legislation that committees will mark up this week.
More than 30 states have laws on the books to allow dying patients the right to try experimental treatments. But these treatments may not be covered by insurance, and ethicists worry vulnerable people could be exploited near the end of their lives. The laws may also duplicate a process the FDA already has in place.
A new study shows that 83 percent of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
President Trump called on Republicans and Democrats to work together to repeal and replace Obamacare.
Epinephrine, the active ingredient in EpiPens, expires after 18 months, and the auto-injector device can’t be refilled or reused. Health professionals are looking for work-arounds they say could save the health system millions.
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
© 2026 KFF